AR048434A1 - Derivados de eter del [1,2,3] triazol - Google Patents

Derivados de eter del [1,2,3] triazol

Info

Publication number
AR048434A1
AR048434A1 ARP050101022A ARP050101022A AR048434A1 AR 048434 A1 AR048434 A1 AR 048434A1 AR P050101022 A ARP050101022 A AR P050101022A AR P050101022 A ARP050101022 A AR P050101022A AR 048434 A1 AR048434 A1 AR 048434A1
Authority
AR
Argentina
Prior art keywords
alkyl
halogen
hydrogen
eter
triazol
Prior art date
Application number
ARP050101022A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR048434A1 publication Critical patent/AR048434A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Métodos de preparacion, composiciones farmacéuticas que los contienen y usos para el control o prevencion de enfermedades como el cáncer. Reivindicacion 1: Los compuestos de formula (1), en donde R1 es -O-alquilo; -S-alquilo; -NH-alquilo; todos los grupos alquilo pueden ser sustituidos opcionalmente con uno o más átomos de halogenos; R2 es hidrogeno; o halogeno; y R3 es hidrogeno; o alternativamente R1 y R2 junto con átomos de carbono a los cuales se une un anillo heterocíclico de 5 o 6 miembros, siendo opcionalmente sustituido con uno o varios átomos de halogeno; y R3 es hidrogeno o halogeno; G es oxígeno; o azufre; y R4 es hidrogeno; C1-3 alquilo; C1-3 alcoxilo; o halogeno; y sales farmacéuticamente aceptables de estos.
ARP050101022A 2004-03-18 2005-03-16 Derivados de eter del [1,2,3] triazol AR048434A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04006509 2004-03-18

Publications (1)

Publication Number Publication Date
AR048434A1 true AR048434A1 (es) 2006-04-26

Family

ID=34924516

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101022A AR048434A1 (es) 2004-03-18 2005-03-16 Derivados de eter del [1,2,3] triazol

Country Status (15)

Country Link
US (1) US7432291B2 (es)
EP (1) EP1727815B1 (es)
JP (1) JP2007529460A (es)
KR (1) KR100836552B1 (es)
CN (1) CN1930154A (es)
AR (1) AR048434A1 (es)
AT (1) ATE365736T1 (es)
AU (1) AU2005223335A1 (es)
BR (1) BRPI0508925A (es)
CA (1) CA2559553A1 (es)
DE (1) DE602005001505T2 (es)
ES (1) ES2289699T3 (es)
RU (1) RU2006136523A (es)
TW (1) TW200533346A (es)
WO (1) WO2005090338A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103189370B (zh) * 2010-11-09 2015-07-08 霍夫曼-拉罗奇有限公司 作为gaba受体用配体的三唑衍生物
US8742097B2 (en) * 2010-11-09 2014-06-03 Hoffmann-La Roche Inc. Triazole compounds I
CA2995617A1 (en) * 2017-11-03 2019-05-03 Universite De Montreal Heterocyclic mitochondrial activity inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1077107C (zh) 1996-07-19 2002-01-02 武田药品工业株式会社 杂环化合物、其制备和用途
PE20011178A1 (es) * 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
US6984653B2 (en) 2001-10-05 2006-01-10 Takeda Pharmaceutical Company Limited Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
WO2003059907A1 (fr) * 2002-01-17 2003-07-24 Takeda Chemical Industries, Ltd. Composes heterocycliques azotes : procede de preparation et d'utilisation
JP2003277379A (ja) * 2002-01-17 2003-10-02 Takeda Chem Ind Ltd 含窒素複素環化合物、その製造法および用途
TW200531688A (en) * 2004-03-05 2005-10-01 Hoffmann La Roche Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
US7163953B2 (en) * 2004-05-25 2007-01-16 Hoffmann-La Roche Inc. Benzylether derivatives

Also Published As

Publication number Publication date
KR100836552B1 (ko) 2008-06-10
CA2559553A1 (en) 2005-09-29
ATE365736T1 (de) 2007-07-15
CN1930154A (zh) 2007-03-14
TW200533346A (en) 2005-10-16
US7432291B2 (en) 2008-10-07
KR20060124757A (ko) 2006-12-05
EP1727815A1 (en) 2006-12-06
WO2005090338A1 (en) 2005-09-29
US20050209290A1 (en) 2005-09-22
ES2289699T3 (es) 2008-02-01
AU2005223335A1 (en) 2005-09-29
DE602005001505D1 (de) 2007-08-09
BRPI0508925A (pt) 2007-08-14
JP2007529460A (ja) 2007-10-25
DE602005001505T2 (de) 2008-02-28
EP1727815B1 (en) 2007-06-27
RU2006136523A (ru) 2008-04-27

Similar Documents

Publication Publication Date Title
PE20130155A1 (es) Derivados de ariletinilo
BRPI0718966B8 (pt) composto, composição farmacêutica, inibidor plk1 e agente antitumoral
CO6251260A2 (es) Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c.
AR048642A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida utiles como antagonistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento
AR035892A1 (es) Derivados de oxazol, proceso para su preparacion, composiciones farmaceuticas que los comprenden, y el uso de dichos compuestos en la preparacion de medicamentos
AR071323A1 (es) Derivados heterociclicos de piridazinonas activadores de glucoquinasas, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de la diabetes mellitus tipo ii.
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
NO20064309L (no) Azabicyklo(3.1.0)heksanderivater anvendelige som modulatorer for dopamin D3 receptorer
PE20040832A1 (es) Derivados de indolil pirazinona
PE20081362A1 (es) DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K
AR082886A1 (es) Compuestos y composiciones farmaceuticas que los contienen
AR079334A1 (es) Derivados de oxazin amino
AR070221A1 (es) Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
EA201101566A1 (ru) Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ
AR078163A1 (es) Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes
ATE487715T1 (de) Triazolderivate als modulatoren von dopamin-d3- rezeptoren
AR069480A1 (es) Derivados de 2-amino-pirimidina
NO20085216L (no) Benzimidazoler og deres anvendelse i behandlingen av diabetes
AR040626A1 (es) Derivados de quinolina utiles como ligandos del receptor del neuropeptido y (npy)
PE20081504A1 (es) Compuestos de biciclocarboxiamida sustituidos
MX2010000658A (es) Derivados de pirimidina 934.
AR073565A1 (es) Derivados de bencimidazol, procesos de preparacion y composiciones farmaceuticas que los contienen
MY162998A (en) Ethynyl derivatives
PE20120900A1 (es) Compuestos heterociclicos de fenoximetilo
AR047958A1 (es) Derivados de 1-bencil-5-piperazin-1-il-3,4 dihidro-1h-quinazolin-2-ona y sus derivados 1h-benzo(1,2,6)tiadiazina-2,2-dioxidos y 1,4-dihidro-benzo(d)(1,3)oxazinas-2-ona,como moduladores del receptor 5-ht,para el tratamiento de enfermedades del sistema nervioso central.

Legal Events

Date Code Title Description
FB Suspension of granting procedure